LG AI연구원, 디앤디파마텍과 차세대 펩타이드 신약 공동 개발
AI Summary
The US Commerce Department blocked worldwide access to Anthropic's Mithos model, citing national security concerns about its ability to identify system vulnerabilities and develop exploits. The measure sparked debate among security experts who warn that restricting access could paradoxically weaken American cybersecurity, while Korean technology companies advance their own AI infrastructure and application platforms.
Progressive: Progressive-leaning outlets report concerns from security experts that government export restrictions on advanced AI models could undermine US cybersecurity capabilities rather than enhance them, characterizing the policy as strategically counterproductive.
Moderate: Centrist outlets focus on governance challenges in Korean AI initiatives and ongoing infrastructure developments across the sector, including pharmaceutical companies' drug discovery platforms and global computing resources markets.
Conservative: Conservative-leaning outlets stress the Mithos model's dangerous hacking and malware-development capabilities as vindicating government safeguards, emphasizing the technical risks that justify export controls.
(서울=연합뉴스) 임성호 기자 = LG AI연구원은 디앤디파마텍과 인공지능(AI) 기반 차세대 펩타이드 신약 공동 개발 사업 본계약을 체결했다고...
이 뉴스, 독자들은 어떻게 느꼈나요?
첫 반응을 남겨보세요로그인하면 감정 반응에 참여할 수 있어요.